TL;DR — mTOR and AMPK nutrient-sensing kinases bias toward growth and away from repair with age. Caloric moderation and fasting are the oldest lifespan interventions; resveratrol activates AMPKAn energy-sensing enzyme activated when ATP is low — it promotes fat burning, mitochondrial biogenesis, and autophagy. Full glossary →, NMN restores SIRT1/mTORA kinase that acts as a cellular growth sensor — when inhibited, cells shift from growth mode into repair, recycling, and autophagy. Full glossary → balance. Track fasting insulin and eating window — execution lives in Hallmark 5 macroautophagy.
What this hallmark means
Nutrient sensing is the master switch between growth (mTOR, insulin/IGF-1) and repair (AMPK, autophagyThe cellular self-cleaning process that breaks down and recycles damaged proteins, organelles, and pathogens. Full glossary →, sirtuinsLongevity-associated enzymes that repair DNA, regulate metabolism, and control inflammation. Full glossary →). Aging shifts the balance toward chronic mTOR dominance — cells stay in build mode even when they should be cleaning up.
Macroautophagy is the large-scale recycling pathway controlled by this switch. Rapamycin (mTOR inhibitor) is the most replicated lifespan drug in mice — but it is prescription-only with immunosuppressive risks.
| Failure mode | What changes | What you feel |
|---|---|---|
| mTOR hyperactivation | Constant nutrient surplus → growth lock | Weight gain, insulin resistance |
| AMPK decline | Energy-sensing cleanup signal weakens | Metabolic inflexibility, no "fasted clarity" |
| IGF-1 elevation | Growth hormone axis stays anabolic | Visceral fat, elevated cancer-risk signaling |
| SIRT1/NAD+ loss | Counterbalance to mTOR removed | See H5 macroautophagy |
Hallmark 12 · Deregulated nutrient sensing
A primary hallmark — the upstream controller of Hallmark 5 · Macroautophagy. mTOR/AMPK imbalance explains why caloric restriction works. Lifestyle triggers repair; compounds modulate the kinases.
Why this matters for your protocol
This hallmark explains why fasting works and why constant snacking ages cells. TNiC stacks target the enzymatic legs (AMPK, SIRT1) but cannot override a 14-hour daily feeding window.
Intervention hierarchy (evidence-weighted):
- Caloric moderation / fasting — oldest mammalian lifespan intervention; mTOR suppression is the mechanism
- Resveratrol → AMPK — mimics energy deficit; promotes autophagy and mitochondrial biogenesis
- NMN → SIRT1/mTOR balance — sirtuins counterbalance mTOR; NAD+A molecule every cell needs for energy production, DNA repair, and activating longevity genes (sirtuins). Full glossary → decline removes this brake
- Metformin (AMPK activator) — TAME trial; prescription (PMID 26579537)
- Rapamycin (mTOR inhibitor) — PEARL trial; prescription-only, immunosuppressive risks (PMID 19587683)
Caloric restriction consistently extends lifespan in mammals via mTOR suppression and AMPK activation. Human time-restricted eating trials improve insulin sensitivity and inflammatory markers — the accessible consumer protocol for nutrient sensing reset.
Practical intervention map
| Lever | Mechanism | Evidence | TNiC resource |
|---|---|---|---|
| Caloric moderation / TRE | mTOR ↓, AMPK ↑ | Tier A | Nutrition |
| Resveratrol PM | AMPK mimetic | Tier B | Resveratrol |
| NMN AM | SIRT1 → mTOR counterbalance | Tier B | NMN |
| Zone 2 + resistance | AMPK + glucose disposal | Tier A | Exercise |
| Autophagy execution | Macroautophagy flux | Tier A | H5 Macroautophagy |
← Swipe for more columns →
Your 90-day nutrient sensing protocol
Weeks 1–4: Log daily eating window. Target 16:8 minimum. Reduce refined sugar and late-night eating.
Weeks 5–8: Add protein timing (larger meals earlier, lighter PM). Retest fasting insulin at week 8.
Weeks 9–12: Add SIRT1 pair if TRE ≥85% and glucose stable.
Decision point at week 12: Fasting insulin ↓ or stable in optimal range → continue 6 more months. Rising → audit visceral fat and alcohol before compounds.
Which nutrient sensing path first?
Fasting insulin above optimal OR HbA1c ≥5.7%?
node | Already on metformin or GLP-1 agonist?
redflag | Physician coordination — do not stack high-dose resveratrol without drug interaction review
TRE 16:8 + Zone 2 for 8 weeks → retest → add SIRT1 pair if flat
node | Eating window >12 hours daily?
Nutrition window sprint 4 weeks before any compound
Maintain TRE; optional NMN if age 45+ and NAD+ low
Type 1 diabetes, pregnancy, or BMI <18.5 — physician-led program only; no unsupervised fasting
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
What to measure
| Signal | Type | Frequency | Success looks like |
|---|---|---|---|
| Fasting insulin | Lab | Baseline, 8 wk, 6 mo | Lower quartile for age |
| IGF-1 | Lab | Baseline, 6 mo | Age-appropriate, not elevated |
| Fasting glucose / HbA1c | Lab | Baseline, 12 wk | Glucose <100; HbA1c <5.7% |
| Ketone bodies (optional) | Home | Weekly AM | Brief elevation in extended fasts |
| Eating window | Log | Daily | ≥16h fasted |
← Swipe for more columns →
Fasting insulin (μIU/mL)
Elevated
Daily fast (hours)
<12
HbA1c (%)
5.7–6.0
Fasting insulin (μIU/mL)
Optimal range for age
Daily fast (hours)
≥16
HbA1c (%)
<5.7
Track nutrient sensing labs
Log fasting insulin, glucose, and optional IGF-1 at baseline and week 12.
Open Labs hubRed flags — when to pause or escalate
Stop and consult before intensifying
- Rapamycin or immunosuppressants — mTOR inhibition requires specialist oversight; never self-source
- Type 1 diabetes or insulin therapy — fasting and AMPK activators risk hypoglycemia
- Active infection or immunocompromise — mTOR is required for immune function; pause aggressive restriction
Synergies worth knowing
| Stack | Covers | Best for |
|---|---|---|
| H5 Macroautophagy | Execution pathway | Always pair with H12 |
| SIRT1 pair | NAD+ + AMPK | Post-TRE foundation |
| NAD+ Mito Stack | Full mito + sensing axis | Age 50+ with metabolic drift |
Build your stack
Nutrient sensing scores highest when TRE and exercise pillars are enabled — compounds layer on after lifestyle registers.
Open Stack ArchitectPersonal results template
My nutrient sensing log
| Date | Week | Fast window (h) | Fasting insulin | Fasting glucose | NMN AM | Resv PM | Notes |
|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | Baseline |
| YYYY-MM-DD | 8 | — | — | — | — | — | Lab checkpoint |
| YYYY-MM-DD | 12 | — | — | — | — | — | Primary endpoint |
← Swipe for more columns →
Personal response criteria: - Meaningful: Fasting insulin improved or stable-optimal + ≥16h fast 6+ days/week - Plateau: Tighten eating window or add 24h monthly fast before dose escalation - Adverse: Hypoglycemia, menstrual disruption, or weight loss >5% unintentional → stop, physician consult
Further reading
- Lamming et al. — rapamycin and mTOR in aging (PMID 19587683)
- Barzilai — TAME metformin trial framework (PMID 26579537)
- Hallmark 5: Disabled Macroautophagy — macroautophagy execution
References
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.